The Nordic countries, or the Nordics, are a geographical and cultural region in Northern Europe and the North Atlantic, where they are most commonly known as Norden (literally "the North").

The region includes Denmark, Finland, Iceland, Norway, and Sweden and has approx. 27 million inhabitants.

Contact us

Do you want to learn more about our services and previous projects? Give us a heads up and one of our experts will reach out to you.

Clas Lindbergson

FrostPharma Head of Business Development

Karin Torberger

FrostPharma Director Business Development

Nordics in brief

The Nordic countries have much in common in their way of life, history, religion and social structure. The Nordic countries have a long history of political unions and other close relations, but do not form a singular entity today.

Each of the Nordic countries has its own economic and social models, sometimes with large differences from its neighbors. Nordic countries share the Nordic model of economy and social structure: a market economy is combined with strong labour unions and a universalist welfare sector financed by heavy taxes.

There is a high degree of income redistribution and little social unrest and these include support for said "universalist" welfare state aimed specifically at enhancing individual autonomy and promoting social mobility.


Sales and Marketing

Entering the European market is not easy. 44 countries with different healthcare systems. What is your strategy? Apart from the Big-5, what do you do with the other 28 countries? We offer a solution for 28 countries. Sales and marketing is our core business.

Learn more


We manage, through our logistic partners with their regional warehouses, the distribution to our region (28 countries). They have the capability to handle the most demanding of specialized product order management, storage, handling and distribution requirements.

Learn more

Early Market Research

You know that market research is critical. It provides customer insights, competitive intelligence, behavioural tendencies, and product positioning. And market research increasingly is becoming an important component for linking R&D and marketing teams.

Learn more

Market Access

Achieving reimbursement and getting the right price are the 2 most important drivers for a successful launch of an innovative pharmaceuticals in our part of Europe. Health Authorities in any European country decide individually based on their local regulations, policies, framework, social values and available health care budget.

Learn more

Market Authorisation

Unlike other regions, in the EU a number of options is available to obtain a marketing authorisation. Centralised at the European Medicines Agency in Amsterdam or decentralised with the individual competent authorities of the member states, each marketing authorisation application procedure has its pros and cons. In the case of Switzerland, it has its own regulatory authority, Swissmedic, and processes.

Learn more


Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Learn more

How about bringing your pharmaceuticals to 200 million Europeans? We are specialized in the Benelux, the Baltics and the CEE region as well.

Experts in the Nordics

We are your experts in commercialising specialized pharmaceuticals in the Nordics. What does that means? What are the hurdles and how to overcome these?

Although the Nordics seems like a strong union, the 5 countries individually have own procedures on pricing and reimbursement. We know these procedures and timelines. Please share your business case with us, and we will help you in eventually commercialising your pharmaceuticals in the Nordics. At hospitals, one-to one meetings are no longer an option. Pre-booked group-meetings is the standard.